147 related articles for article (PubMed ID: 30546643)
1. Multidisciplinary approach for primary cardiac lymphoma associated with hemodynamic failure caused by tricuspid valve obstruction.
Yamamoto M; Nishimori H; Kondo N; Terauchi Y; Tashiro M; Fukutomi T; Yabe T; Orihashi K
J Cardiol Cases; 2016 Jun; 13(6):189-192. PubMed ID: 30546643
[TBL] [Abstract][Full Text] [Related]
2. A Rare Case of Diffuse Large B Cell Lymphoma Presenting as a Cardiac Mass.
Yousif P; Kotecha A; Thakur A; Ismail HM
Am J Case Rep; 2019 Dec; 20():1821-1825. PubMed ID: 31809493
[TBL] [Abstract][Full Text] [Related]
3. Successful Management of Primary Cardiac Lymphoma with Minimal Debulking Surgery Combined with Adjuvant Chemotherapy.
Hong TH; Jeong DS
Heart Surg Forum; 2015 Dec; 18(6):E242-4. PubMed ID: 26726713
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of primary cardiac lymphoma by rituximab-CHOP and high-dose chemotherapy with autologous peripheral blood stem cell transplantation.
Nonami A; Takenaka K; Kamezaki K; Miyamoto T; Harada N; Nagafuji K; Teshima T; Harada M
Int J Hematol; 2007 Apr; 85(3):264-6. PubMed ID: 17483065
[TBL] [Abstract][Full Text] [Related]
5. Treatment of malignant primary cardiac lymphoma with tumor resection using minimally invasive cardiac surgery.
Endo Y; Nakamura Y; Kuroda M; Nakanishi Y; Ito Y; Hori T; Okamoto R; Konishi H
J Cardiothorac Surg; 2018 Sep; 13(1):97. PubMed ID: 30257692
[TBL] [Abstract][Full Text] [Related]
6. Successful surgical resection and reconstruction for a huge primary cardiac lymphoma filling the right heart.
Taguchi T; Fukushima S; Yajima S; Saito T; Kawamoto N; Tadokoro N; Kakuta T; Fujita T
J Card Surg; 2021 Jan; 36(1):342-344. PubMed ID: 33124696
[TBL] [Abstract][Full Text] [Related]
7. High-dose chemotherapy with autologous stem cell transplantation following systemic chemotherapy, prophylactic intrathecal methotrexate, and radiotherapy prevents relapse and improves the outcome of advanced stage primary testicular lymphoma even with cardiac involvement.
Lee S; Yamauchi T; Kinoshita K; Imamura S; Kamiya K
J Clin Exp Hematop; 2017 Oct; 57(2):64-68. PubMed ID: 28883219
[TBL] [Abstract][Full Text] [Related]
8. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
[TBL] [Abstract][Full Text] [Related]
9. Long-term disease-free survival of patients with primary cardiac lymphoma treated with systemic chemotherapy and radiotherapy.
Shin DY; Lee YG; Lee HJ; Choi S; Park JJ; Kim DW
Korean J Hematol; 2010 Dec; 45(4):282-5. PubMed ID: 21253433
[TBL] [Abstract][Full Text] [Related]
10. Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
Fridrik MA; Jaeger U; Petzer A; Willenbacher W; Keil F; Lang A; Andel J; Burgstaller S; Krieger O; Oberaigner W; Sihorsch K; Greil R
Eur J Cancer; 2016 May; 58():112-21. PubMed ID: 26990931
[TBL] [Abstract][Full Text] [Related]
11. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
[TBL] [Abstract][Full Text] [Related]
12. A rare case of primary cardiac lymphoma and the role of early surgical debulking: a case report.
Grantomo J; Pratita J; Rachmat J; Saraswati M
Eur Heart J Case Rep; 2018 Dec; 2(4):yty116. PubMed ID: 31020192
[TBL] [Abstract][Full Text] [Related]
13. Complete Regression of Primary Cardiac Lymphoma With Dose-Attenuated R-CVP Chemotherapeutic Regimen.
Mandal AKJ; Selby FL; Deoraj S; Metaxa S; Missouris CG
JACC Case Rep; 2019 Oct; 1(3):332-336. PubMed ID: 34316819
[TBL] [Abstract][Full Text] [Related]
14. [Successful Surgical Treatment of Primary Cardiac Lymphoma Detected with the Onset of Acute Heart Failure;Report of a Case].
Inoue R; Nakamura B; Inagaki M; Fujii T; Hirano K; Maze Y; Tokui T
Kyobu Geka; 2017 Nov; 70(12):1021-1024. PubMed ID: 29104202
[TBL] [Abstract][Full Text] [Related]
15. A Patent Foramen Ovale Grants Cardiac Output Over an Obstructive Primary Cardiac Lymphoma.
Carvalho RR; Sousa JA; Ribeiras R; Fernandes R; Haas A; Neves J; Andrade MJ
JACC Case Rep; 2022 Oct; 4(20):1353-1356. PubMed ID: 36299656
[TBL] [Abstract][Full Text] [Related]
16. Primary Cardiac Lymphoma Presenting with Thrombocytopenia, Right Heart Failure, and Cardiogenic Shock.
Kurniawan S; Mathur G; Bogun Y; Kidson-Gerber G
Case Rep Hematol; 2023; 2023():5501131. PubMed ID: 36643956
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological features of primary cardiac CD5-positive and bcl-2 and C-MYC double expression diffuse large B-cell lymphoma].
Zhang F; Luo DL; Chen Y; Liu J; Luo LQ; He J; Yan JH; Xu J; Luo XL; Liu YH
Zhonghua Bing Li Xue Za Zhi; 2019 Dec; 48(12):951-954. PubMed ID: 31818069
[No Abstract] [Full Text] [Related]
18. Extracorporeal Membrane Oxygenation with rituximab-combined chemotherapy in AIDS-associated primary cardiac lymphoma: A case report.
Fuseya H; Yoshimura T; Tsutsumi M; Nakaya Y; Horiuchi M; Yoshida M; Hayashi Y; Nakao T; Inoue T; Yamane T
Clin Case Rep; 2021 Aug; 9(8):e04704. PubMed ID: 34466258
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis.
Linschoten M; Kamphuis JAM; van Rhenen A; Bosman LP; Cramer MJ; Doevendans PA; Teske AJ; Asselbergs FW
Lancet Haematol; 2020 Apr; 7(4):e295-e308. PubMed ID: 32135128
[TBL] [Abstract][Full Text] [Related]
20. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.
Pfreundschuh M; Trümper L; Osterborg A; Pettengell R; Trneny M; Imrie K; Ma D; Gill D; Walewski J; Zinzani PL; Stahel R; Kvaloy S; Shpilberg O; Jaeger U; Hansen M; Lehtinen T; López-Guillermo A; Corrado C; Scheliga A; Milpied N; Mendila M; Rashford M; Kuhnt E; Loeffler M;
Lancet Oncol; 2006 May; 7(5):379-91. PubMed ID: 16648042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
